carbamazepine has been researched along with Convulsive Generalized Seizure Disorder in 131 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 9.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
| " This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy." | 9.08 | Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997) |
| "To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset focal or generalized seizures." | 8.98 | Clobazam monotherapy for focal or generalized seizures. ( Anand, V; Arya, R; Garg, SK; Giridharan, N, 2018) |
| "The authors analyze the published evidence on the efficacy of perampanel against secondarily generalized seizures (SGS) and report the currently available development of intravenous (IV) formulations of carbamazepine (CBZ), commenting on their potential in the clinical setting." | 8.90 | Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. ( Citraro, R; De Sarro, G; Franco, V; Grillo, E; Iudice, A; Russo, E, 2014) |
| "To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset partial or generalized seizures." | 8.90 | Clobazam monotherapy for partial-onset or generalized-onset seizures. ( Anand, V; Arya, R; Garg, SK; Michael, BD, 2014) |
| "To evaluate the efficacy and tolerability of extended release carbamazepine (finlepsin-retard and tegretol CR) in adult patients with new-onset focal epilepsy (FE) with the assessment of epileptiform activity index (EAI)." | 8.02 | [The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Vlasov, PN, 2021) |
| "56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina." | 7.91 | Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina. ( Basic, S; Bozina, N; Markovic, I; Pejanovic-Skobic, N, 2019) |
| "Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier - screening in risk patients is recommended A 32-year-old woman, adopted from Indonesia, developed Stevens-Johnsons syndrome (SJS)/toxic epidermal necrolysis (TEN) after initiating carbamazepine treatment for epilepsy." | 7.85 | [Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier – screening in risk patients is recommended]. ( Anastasopoulou, S; Karlsson, M; Komuda, M; Presman, B; Tomson, T, 2017) |
| "Carbamazepine controlled multiple seizure types and did not induce or increase the frequency of myoclonic or absence seizures in these patients." | 7.80 | Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy. ( Kenyon, K; Mintzer, S; Nei, M, 2014) |
| " We compared seizure frequency and mean intravenous benzodiazepine dose required to control absence status epilepticus, intraindividually in subjects on carbamazepine or phenytoin before and after discontinuation of these compounds, and interindividually to subjects without treatment or receiving other drugs." | 7.70 | Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine. ( Osorio, I; Peltzer, JN; Reed, RC, 2000) |
| "Relapse of seizures can have major adverse psychosocial consequences and also may carry a risk of morbidity and mortality." | 7.01 | Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy? ( Asadi-Pooya, AA; Mesraoua, B; Perucca, E; Tomson, T, 2023) |
| "Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide." | 6.66 | Current role of carbamazepine and oxcarbazepine in the management of epilepsy. ( Beydoun, A; DuPont, S; Lagae, L; Matta, M; Nagire, V; Zhou, D, 2020) |
| "Lamotrigine is a relatively new AED which is licensed in many countries for use as an initial monotherapy." | 6.43 | Lamotrigine versus carbamazepine monotherapy for epilepsy. ( Gamble, CL; Marson, AG; Williamson, PR, 2006) |
| "Disulfiram has been widely used for over six decades in the treatment of alcohol dependence, as an aversive therapeutic agent." | 5.62 | Disulfiram-induced epileptic seizures. ( Mendes, MA; Nogueira, V; Pereira, I; Teixeira, J, 2021) |
| "To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 5.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
| " This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy." | 5.08 | Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997) |
| "To review the time to treatment failure, remission and first seizure with carbamazepine compared with phenobarbitone when used as monotherapy in people with focal onset seizures (simple or complex focal and secondarily generalised), or generalised onset tonic-clonic seizures (with or without other generalised seizure types)." | 4.98 | Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C, 2018) |
| "To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset focal or generalized seizures." | 4.98 | Clobazam monotherapy for focal or generalized seizures. ( Anand, V; Arya, R; Garg, SK; Giridharan, N, 2018) |
| "To review the time to withdrawal, remission, and first seizure of carbamazepine compared with phenobarbitone when used as monotherapy in people with partial onset seizures (simple or complex partial and secondarily generalised) or generalised onset tonic-clonic seizures (with or without other generalised seizure types)." | 4.93 | Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016) |
| "The authors analyze the published evidence on the efficacy of perampanel against secondarily generalized seizures (SGS) and report the currently available development of intravenous (IV) formulations of carbamazepine (CBZ), commenting on their potential in the clinical setting." | 4.90 | Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. ( Citraro, R; De Sarro, G; Franco, V; Grillo, E; Iudice, A; Russo, E, 2014) |
| "To evaluate the efficacy, effectiveness, tolerability and safety of clobazam as monotherapy in people with new-onset partial or generalized seizures." | 4.90 | Clobazam monotherapy for partial-onset or generalized-onset seizures. ( Anand, V; Arya, R; Garg, SK; Michael, BD, 2014) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy." | 4.88 | Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2012) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy." | 4.86 | Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2010) |
| "To evaluate the efficacy and tolerability of extended release carbamazepine (finlepsin-retard and tegretol CR) in adult patients with new-onset focal epilepsy (FE) with the assessment of epileptiform activity index (EAI)." | 4.02 | [The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Vlasov, PN, 2021) |
| "56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina." | 3.91 | Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina. ( Basic, S; Bozina, N; Markovic, I; Pejanovic-Skobic, N, 2019) |
| "Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier - screening in risk patients is recommended A 32-year-old woman, adopted from Indonesia, developed Stevens-Johnsons syndrome (SJS)/toxic epidermal necrolysis (TEN) after initiating carbamazepine treatment for epilepsy." | 3.85 | [Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier – screening in risk patients is recommended]. ( Anastasopoulou, S; Karlsson, M; Komuda, M; Presman, B; Tomson, T, 2017) |
| "Carbamazepine controlled multiple seizure types and did not induce or increase the frequency of myoclonic or absence seizures in these patients." | 3.80 | Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy. ( Kenyon, K; Mintzer, S; Nei, M, 2014) |
| " Antiepileptics (carbamazepine, sodium valproate, zonisamide, clobazam, and topiramate), which are used for complex partial epilepsy or secondary generalized epilepsy in clinical practice, were orally administrated to kindled rats." | 3.76 | The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics. ( Akagi, M; Fujiwara, A; Ishikawa, T; Kaida, Y; Kamei, C; Takechi, K; Watanabe, Y, 2010) |
| " It identifies lamotrigine as a cost-effective alternative to carbamazepine for the treatment of focal epilepsies, but confirms valproate as the most effective drug for the treatment of generalized or unclassified epilepsy." | 3.74 | Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. ( Chadwick, D; Marson, T, 2007) |
| "A child with Sturge-Weber syndrome and a left occipital leptomeningeal angioma developed focal seizures at 6 years of age that responded initially to oxcarbazepine." | 3.74 | Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome. ( Comi, AM; Ewen, JB; Kossoff, EH, 2007) |
| " The paper is about the evolution of these changes in EEG and the assessment of disease recurrence in the course of treatment and upon therapy termination in patients taking valproic acid preparations (VPA) during idiopathic generalized epilepsy (IGE) and those taking carbamazepine (CBZ) preparations during cryptogenic focal epilepsy (CFE)." | 3.72 | [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy]. ( Marszał, E; Szwed-Białozyt, B, 2003) |
| " We compared seizure frequency and mean intravenous benzodiazepine dose required to control absence status epilepticus, intraindividually in subjects on carbamazepine or phenytoin before and after discontinuation of these compounds, and interindividually to subjects without treatment or receiving other drugs." | 3.70 | Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine. ( Osorio, I; Peltzer, JN; Reed, RC, 2000) |
| " Following treatment with antiepileptic drugs (AEDs), the patient developed several rare complications: after beginning therapy with phenytoin, the patient developed pseudolymphoma; after monotherapy with carbamazepine (CBZ), the patient thereafter developed myoclonic jerks of upper and lower limbs upon awakening; after one year of treatment with valproate (VPA) the patient developed clinical and immuno-haematological signs of SLE." | 3.69 | Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p. ( Diomedi, M; Gigli, GL; Masala, C; Placidi, F; Pomponi, MG; Scalise, A; Silvestri, G, 1996) |
| "Relapse of seizures can have major adverse psychosocial consequences and also may carry a risk of morbidity and mortality." | 3.01 | Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy? ( Asadi-Pooya, AA; Mesraoua, B; Perucca, E; Tomson, T, 2023) |
| "Epilepsy is a chronic disease of the central nervous system characterized by recurrent epileptic seizures." | 3.01 | Second Generation of Antiepileptic Drugs and Oxidative Stress. ( Czuczwar, SJ; Kamieniak, M; Kośmider, K; Miziak, B, 2023) |
| "Seizures are among the most common clinical signs in people with glioblastoma." | 3.01 | The complexities underlying epilepsy in people with glioblastoma. ( Cole, AJ; Dietrich, J; Sokolov, E, 2023) |
| "Oxcarbazepine (trileptal) was prescribed in accordance to recommendations and titration schemes (continuous and single-stage) conventional in Russia." | 2.75 | [Efficacy and safety of the mono- and combined therapy with oxcarbazepine in adult patients]. ( Badalian, OL; Burd, SG; Glukhova, LIu, 2010) |
| "First seizures are always challenging for physicians." | 2.72 | Update on first unprovoked seizure in children and adults: A narrative review. ( Carrizosa-Moog, J; Jiménez-Villegas, MJ; Lozano-García, L, 2021) |
| " The rate of patients discontinuing treatment due to adverse events or a lack of efficacy was 19% with CBZ compared to 9% with LTG (not statistically different)." | 2.71 | The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. ( Bergmann, L; Kurlemann, G; Schmitz, B; Siemes, H; Steinhoff, BJ; Ueberall, MA, 2005) |
| "Oxcarbazepine dose was begun at 10 mg/kg/day twice daily and increased to 30 mg/kg/day at the end of the second week." | 2.71 | Oxcarbazepine in the treatment of childhood epilepsy. ( Dirik, E; Kurul, S; Sarioglu, B; Serdaroglu, G; Tutuncuoglu, S, 2003) |
| "Vigabatrin appears to be a reasonable choice for single-drug therapy in the treatment of certain types of seizures." | 2.68 | Newer antiepileptic drugs as monotherapy: data on vigabatrin. ( Fisher, R; Kälviäinen, R; Regesta, G; Tanganelli, P, 1996) |
| " Results of outcome measures, including time to exit, completion rate, and mean time on monotherapy, showed no significant differences among dosage groups." | 2.68 | Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. ( Abou-Khalil, B; Beydoun, A; Cantrell, D; Fischer, J; Garofalo, E; Greiner, M; Harden, C; Hayes, A; Labar, DR; Pierce, M; Ramsay, RE; Sackellares, JC; Uthman, BM, 1997) |
| "Oxcarbazepine (OXC) has been licensed as monotherapy and add-on treatment in epilepsy patients with partial seizures with or without secondarily generalized seizures (PS) and generalized tonic-clonic seizures without partial onset (GTCS)." | 2.68 | A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. ( Brodie, MJ; Christe, W; Krämer, G; Moore, A; Pohlmann, H; Steinhoff, BJ; Vigonius, U, 1997) |
| " Recommendations are made for a higher initial dosage regime for sodium valproate in partial seizures." | 2.67 | A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. ( Cartlidge, NE; Davidson, DL; Easter, DJ; Richens, A, 1994) |
| "Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide." | 2.66 | Current role of carbamazepine and oxcarbazepine in the management of epilepsy. ( Beydoun, A; DuPont, S; Lagae, L; Matta, M; Nagire, V; Zhou, D, 2020) |
| "It is also effective in generalized epilepsy and in several other conditions of the CNS." | 2.61 | An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy. ( Ljung, H; Reimers, A, 2019) |
| "Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
| "Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
| "Carbamazepine is a current first-line treatment for partial onset seizures in the USA and Europe." | 2.55 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C; Weston, J, 2017) |
| "Lamotrigine was significantly less likely to be withdrawn than carbamazepine but the results for time to first seizure suggested that carbamazepine may be superior in terms of seizure control." | 2.53 | Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2016) |
| "Carbamazepine is a current first line treatment for partial onset seizures in the USA and Europe." | 2.52 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2015) |
| "Carbamazepine is a current first-line treatment for partial onset seizures in the USA and Europe." | 2.52 | Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nolan, SJ; Tudur Smith, C; Weston, J, 2015) |
| "Lamotrigine is a relatively new AED which is licensed in many countries for use as an initial monotherapy." | 2.43 | Lamotrigine versus carbamazepine monotherapy for epilepsy. ( Gamble, CL; Marson, AG; Williamson, PR, 2006) |
| "New-onset seizures affect up to 10% of people over their lifetime, however, their health economic impact has not been well-studied." | 1.72 | Prospective multisite cohort study of patient-reported outcomes in adults with new-onset seizures. ( Ademi, Z; Au Yong, HM; Carney, PW; Carrillo de Albornoz, S; Chen, Z; D'Souza, W; Foster, E; Kwan, P; Liew, D; Nicolo, JP; O'Brien, TJ; Pellinen, J; Tailby, C; Vaughan, DN, 2022) |
| "Seizure relapses are the leading cause of admission to emergency rooms (ER) in people with epilepsy." | 1.72 | Factors involved in time reduction between seizure relapses in patients with epilepsy attending emergency rooms in Medellín, Colombia. ( Bernal Cobo, R; Giraldo Castrillón, YM; Giraldo Tapias, LM; Gómez Escobar, T; Rojas-Gualdrón, DF; Rueda Cárdenas, LF; Vásquez Trespalacios, EM; Zapata Berruecos, JF, 2022) |
| "We hypothesized that poor seizure control is associated with new-onset MHC diagnoses and/or new prescription drugs for MHCs." | 1.72 | Incidence of mental health conditions by seizure control among adults with epilepsy in the United States. ( Ferrari, L; Hauser, WA; Schabert, VF; Stern, S; Wade, CT; Willke, RJ, 2022) |
| "Disulfiram has been widely used for over six decades in the treatment of alcohol dependence, as an aversive therapeutic agent." | 1.62 | Disulfiram-induced epileptic seizures. ( Mendes, MA; Nogueira, V; Pereira, I; Teixeira, J, 2021) |
| "Causative drugs for new-onset seizures were further investigated." | 1.62 | Antihistamines as a common cause of new-onset seizures: a single-center observational study. ( Kim, H; Kim, JB; Kim, SH, 2021) |
| "This makes assessing change in seizure rates over time difficult." | 1.56 | Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs. ( Bonnett, LJ; Hutton, JL; Marson, AG, 2020) |
| "Males have a younger age at onset." | 1.51 | Seizures in Down Syndrome: An Update. ( Fatema, K; Rahman, MM, 2019) |
| "Eslicarbazepine acetate is a recently approved antiepileptic drug that is rapidly metabolized to (S)-licarbazepine." | 1.42 | Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy. ( Kim, TH; Petrou, S; Reid, CA, 2015) |
| "Among those with Idiopathic Generalized Epilepsy (46%), generalized tonic clonic seizure was encountered in 74% and absence seizure was observed in 13%." | 1.39 | Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital. ( Chowdhury, AH; Chowdhury, RN; Ghose, SK; Habib, M; Haque, B; Hasan, AT; Hoque, A; Khan, SU; Mohammad, QD; Mondal, BA; Rahman, KM, 2013) |
| "We report a child with idiopathic generalized epilepsy who developed myoclonic seizures and had an abnormal electroencephalogram (EEG) when oral suspension of OXC was introduced." | 1.38 | Myoclonus precipitated by oral suspension of oxcarbazepine in idiopathic generalized epilepsy. ( Deng, S; Huang, L; Luo, R; Mao, M, 2012) |
| "Although a pathogenetic mechanism underlying carbamazepine-induced epileptic negative myoclonus has been proposed, a causative role of carbamazepine for positive myoclonus has not been fully identified." | 1.38 | Carbamazepine-induced non-epileptic myoclonus and tic-like movements. ( Di Rosa, G; Magaudda, A, 2012) |
| "Idiopathic generalized epilepsy (IGE) was diagnosed in 85 cases, cryptogenic focal epilepsy in 107 cases, symptomatic focal epilepsy in 51 cases, unclassified epilepsy in 32 cases." | 1.38 | [Idiopathic generalized epilepsy in young women: choise of treatment strategy]. ( Kotov, AS, 2012) |
| "A woman diagnosed with juvenile myoclonic epilepsy for over 30 years presented with stereotyped episodes of abnormal sensations in both arms." | 1.37 | Fronto-polar epilepsy masquerading as juvenile myoclonic epilepsy. ( Keezer, MR; Nguyen, DK; Saint-Hilaire, JM, 2011) |
| "Subacute sclerosing panencephalitis is a neurodegenerative disease with a poor prognosis." | 1.33 | Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing panencephalitis. ( Aydin, OF; Gürer, YK; Senbil, N, 2006) |
| "Familial rectal pain is a very rare entity that must always be considered as a possible aetiology of any life-threatening event in an infant because of the availability of a very effective treatment." | 1.33 | Familial rectal pain: a familial autonomic disorder as a cause of paroxysmal attacks in the newborn baby. ( Arbuès, AS; Bednarek, N; Morville, P; Motte, J; Plouin, P; Sabouraud, P, 2005) |
| "Oxcarbazepine (OXC) is a new drug chemically related to CBZ." | 1.32 | Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. ( Baldy-Moulinier, M; Crespel, A; Gelisse, P; Genton, P; Kuate, C; Pesenti, A, 2004) |
| "To report a new form of reflex epilepsy in which the seizures are repeatedly and exclusively triggered by answering the telephone." | 1.32 | Telephone-induced seizures: a new type of reflex epilepsy. ( Alberto Tassinari, C; Bisulli, F; Cantalupo, G; de Haan, GJ; Gardella, E; Kasteleijn-Nolst Trenité, DG; Michelucci, R; Nichelli, P; Nobile, C; Tinuper, P; Zaniboni, A, 2004) |
| "Men with epilepsy have reduced fertility, and antiepileptic drugs may affect semen quality." | 1.32 | Effect of epilepsy and antiepileptic drugs on male reproductive health. ( Isojärvi, JI; Juntunen, KS; Löfgren, E; Päivänsalo, M; Pakarinen, AJ; Rautakorpi, I; Tuomivaara, L, 2004) |
| "One hundred seventy-eight men had focal epilepsy (117 of these had temporal lobe epilepsy [TLE]) and 22 idiopathic generalized epilepsy (IGE)." | 1.32 | Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. ( Bauer, J; Blumenthal, S; Reuber, M; Stoffel-Wagner, B, 2004) |
| " The LTG dosage was increased step by step until clinical response or side effects were observed." | 1.30 | No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children. ( Boreus, LO; Eriksson, AS, 1997) |
| "Epilepsy is a relatively common problem in children, adults and the elderly." | 1.30 | Treatment of the epileptic patient in the dental office. ( Haller, JS; Kennedy, BT, 1998) |
| "Carbamazepine treatment resulted in prolongation of peak latencies of waves I-III-V and interpeak intervals I-III and I-V." | 1.29 | Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. ( Cenani, A; Dirican, A; Keskin, G; Senocak, D; Sozuer, D; Yalcin, E; Yuksel, A, 1995) |
| "Idiopathic generalized epilepsy (IGE) was diagnosed in 12 cases and partial epilepsy (PE) in 23 cases." | 1.29 | Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. ( Costelli, P; Fonzi, S; Galimberti, CA; Manni, R; Murialdo, G; Parodi, C; Polleri, A; Solinas, GP; Tartara, A; Torre, F, 1994) |
| "In 3 patients the addition of fluvoxamine to a constant dosage of carbamazepine (CZP) caused a substantial rise of plasma CZP accompanied by symptoms of intoxication." | 1.28 | Interaction between carbamazepine and fluvoxamine. ( Fritze, J; Lanczik, M; Unsorg, B, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 37 (28.24) | 18.2507 |
| 2000's | 39 (29.77) | 29.6817 |
| 2010's | 38 (29.01) | 24.3611 |
| 2020's | 17 (12.98) | 2.80 |
| Authors | Studies |
|---|---|
| Bernal Cobo, R | 1 |
| Giraldo Tapias, LM | 1 |
| Gómez Escobar, T | 1 |
| Rueda Cárdenas, LF | 1 |
| Zapata Berruecos, JF | 1 |
| Vásquez Trespalacios, EM | 1 |
| Giraldo Castrillón, YM | 1 |
| Rojas-Gualdrón, DF | 1 |
| Foster, E | 1 |
| Chen, Z | 1 |
| Vaughan, DN | 1 |
| Tailby, C | 1 |
| Carney, PW | 1 |
| D'Souza, W | 1 |
| Au Yong, HM | 1 |
| Nicolo, JP | 1 |
| Pellinen, J | 1 |
| Carrillo de Albornoz, S | 1 |
| Liew, D | 1 |
| O'Brien, TJ | 1 |
| Kwan, P | 1 |
| Ademi, Z | 1 |
| Hochbaum, M | 1 |
| Kienitz, R | 1 |
| Rosenow, F | 1 |
| Schulz, J | 1 |
| Habermehl, L | 1 |
| Langenbruch, L | 1 |
| Kovac, S | 1 |
| Knake, S | 1 |
| von Podewils, F | 1 |
| von Brauchitsch, S | 1 |
| Hamacher, M | 1 |
| Strzelczyk, A | 1 |
| Willems, LM | 1 |
| Asadi-Pooya, AA | 2 |
| Patel, AA | 1 |
| Trinka, E | 2 |
| Mazurkiewicz-Beldzinska, M | 1 |
| Cross, JH | 1 |
| Welty, TE | 1 |
| Schabert, VF | 1 |
| Stern, S | 1 |
| Ferrari, L | 1 |
| Wade, CT | 1 |
| Willke, RJ | 1 |
| Hauser, WA | 1 |
| Kośmider, K | 1 |
| Kamieniak, M | 1 |
| Czuczwar, SJ | 1 |
| Miziak, B | 1 |
| Mesraoua, B | 1 |
| Perucca, E | 2 |
| Tomson, T | 2 |
| Sokolov, E | 1 |
| Dietrich, J | 1 |
| Cole, AJ | 1 |
| Rahman, MM | 1 |
| Fatema, K | 1 |
| Pejanovic-Skobic, N | 1 |
| Markovic, I | 1 |
| Bozina, N | 1 |
| Basic, S | 1 |
| Bonnett, LJ | 1 |
| Hutton, JL | 2 |
| Marson, AG | 18 |
| Zhang, W | 1 |
| Bu, H | 1 |
| Li, Y | 1 |
| Han, X | 1 |
| He, J | 1 |
| Jia, L | 1 |
| Wang, W | 1 |
| Beydoun, A | 5 |
| DuPont, S | 1 |
| Zhou, D | 1 |
| Matta, M | 1 |
| Nagire, V | 1 |
| Lagae, L | 1 |
| Kim, H | 1 |
| Kim, SH | 1 |
| Kim, JB | 1 |
| Nogueira, V | 1 |
| Mendes, MA | 1 |
| Pereira, I | 1 |
| Teixeira, J | 1 |
| Karlov, VA | 1 |
| Vlasov, PN | 1 |
| Kozhokaru, AB | 1 |
| Orlova, AS | 1 |
| Jiménez-Villegas, MJ | 1 |
| Lozano-García, L | 1 |
| Carrizosa-Moog, J | 1 |
| Li, N | 1 |
| Li, J | 1 |
| Zhao, D | 1 |
| Lin, W | 1 |
| Panda, PK | 1 |
| Sharawat, IK | 1 |
| Panda, P | 1 |
| Dawman, L | 1 |
| Kasinathan, A | 1 |
| Wang, Y | 1 |
| Chen, YB | 1 |
| Zhang, YQ | 1 |
| Luo, R | 2 |
| Wang, H | 1 |
| Lv, JL | 1 |
| Wang, D | 1 |
| Zhu, SQ | 1 |
| Lin, ZD | 1 |
| Qin, J | 1 |
| Nevitt, SJ | 6 |
| Sudell, M | 4 |
| Weston, J | 8 |
| Tudur Smith, C | 12 |
| Arya, R | 2 |
| Giridharan, N | 1 |
| Anand, V | 2 |
| Garg, SK | 2 |
| Reimers, A | 1 |
| Ljung, H | 1 |
| Habib, M | 1 |
| Khan, SU | 1 |
| Hoque, A | 1 |
| Mondal, BA | 1 |
| Hasan, AT | 1 |
| Chowdhury, RN | 1 |
| Haque, B | 1 |
| Rahman, KM | 1 |
| Chowdhury, AH | 1 |
| Ghose, SK | 1 |
| Mohammad, QD | 1 |
| Kenyon, K | 1 |
| Mintzer, S | 1 |
| Nei, M | 1 |
| Franco, V | 1 |
| Iudice, A | 1 |
| Grillo, E | 1 |
| Citraro, R | 1 |
| De Sarro, G | 1 |
| Russo, E | 1 |
| Michael, BD | 1 |
| El-Farahaty, RM | 1 |
| El-Mitwalli, A | 1 |
| Azzam, H | 1 |
| Wasel, Y | 1 |
| Elrakhawy, MM | 1 |
| Hasaneen, BM | 1 |
| Kim, TH | 1 |
| Reid, CA | 1 |
| Petrou, S | 1 |
| Nolan, SJ | 5 |
| Anastasopoulou, S | 1 |
| Komuda, M | 1 |
| Presman, B | 1 |
| Karlsson, M | 1 |
| Alajbegović, A | 1 |
| Loga, N | 1 |
| Alajbegović, S | 1 |
| Suljić, E | 1 |
| Fujiwara, A | 1 |
| Watanabe, Y | 1 |
| Takechi, K | 1 |
| Ishikawa, T | 1 |
| Kaida, Y | 1 |
| Akagi, M | 1 |
| Kamei, C | 1 |
| Zheleznova, EV | 1 |
| Kalinin, VV | 1 |
| Zemlyanaya, AA | 1 |
| Sokolova, LV | 1 |
| Medvedev, IL | 1 |
| Burd, SG | 1 |
| Glukhova, LIu | 1 |
| Badalian, OL | 1 |
| Maguire, M | 2 |
| Ramaratnam, S | 2 |
| Karmon, Y | 1 |
| Inbar, E | 1 |
| Gadoth, N | 1 |
| Aggarwal, A | 1 |
| Rastogi, N | 1 |
| Mittal, H | 1 |
| Chillar, N | 1 |
| Patil, R | 1 |
| Keezer, MR | 1 |
| Saint-Hilaire, JM | 1 |
| Nguyen, DK | 1 |
| Deng, S | 1 |
| Mao, M | 1 |
| Huang, L | 1 |
| Hajnsek, S | 1 |
| Milavec-Puretic, V | 1 |
| Nankovic, S | 1 |
| Petelin Gadze, Z | 1 |
| Filipcic, I | 1 |
| Bujan Kovac, A | 1 |
| Stulhofer Buzina, D | 1 |
| Magaudda, A | 1 |
| Di Rosa, G | 1 |
| Van Paesschen, W | 1 |
| Kälviäinen, R | 2 |
| Marovac, J | 1 |
| Duncan, B | 1 |
| Buyle, S | 1 |
| Hallström, Y | 1 |
| Hon, P | 1 |
| Muscas, GC | 1 |
| Newton, M | 1 |
| Meencke, HJ | 1 |
| Smith, PE | 1 |
| Pohlmann-Eden, B | 1 |
| Kotov, AS | 1 |
| Sönnichsen, AC | 1 |
| Yoshikawa, H | 1 |
| Honma, T | 1 |
| Yamazaki, S | 1 |
| Abe, T | 1 |
| Bauer, J | 2 |
| Hermann, A | 1 |
| Reuber, M | 2 |
| Williamson, PR | 2 |
| Serdaroglu, G | 1 |
| Kurul, S | 1 |
| Tutuncuoglu, S | 1 |
| Dirik, E | 1 |
| Sarioglu, B | 1 |
| Shahar, E | 1 |
| Barak, S | 1 |
| Yerby, MS | 1 |
| Mukhin, KIu | 1 |
| Petrukhin, AS | 1 |
| Mironov, MB | 1 |
| Szwed-Białozyt, B | 1 |
| Marszał, E | 1 |
| Gates, JR | 1 |
| Blumenthal, S | 1 |
| Stoffel-Wagner, B | 1 |
| Isojärvi, JI | 3 |
| Löfgren, E | 1 |
| Juntunen, KS | 1 |
| Pakarinen, AJ | 3 |
| Päivänsalo, M | 1 |
| Rautakorpi, I | 1 |
| Tuomivaara, L | 1 |
| Michelucci, R | 1 |
| Gardella, E | 1 |
| de Haan, GJ | 1 |
| Bisulli, F | 1 |
| Zaniboni, A | 1 |
| Cantalupo, G | 1 |
| Alberto Tassinari, C | 1 |
| Tinuper, P | 1 |
| Nobile, C | 1 |
| Nichelli, P | 1 |
| Kasteleijn-Nolst Trenité, DG | 1 |
| French, JA | 4 |
| Kanner, AM | 3 |
| Bautista, J | 3 |
| Abou-Khalil, B | 4 |
| Browne, T | 3 |
| Harden, CL | 3 |
| Theodore, WH | 3 |
| Bazil, C | 3 |
| Stern, J | 3 |
| Schachter, SC | 3 |
| Bergen, D | 3 |
| Hirtz, D | 3 |
| Montouris, GD | 3 |
| Nespeca, M | 3 |
| Gidal, B | 3 |
| Marks, WJ | 3 |
| Turk, WR | 3 |
| Fischer, JH | 3 |
| Bourgeois, B | 3 |
| Wilner, A | 3 |
| Faught, RE | 3 |
| Sachdeo, RC | 3 |
| Glauser, TA | 3 |
| Gelisse, P | 1 |
| Genton, P | 1 |
| Kuate, C | 1 |
| Pesenti, A | 1 |
| Baldy-Moulinier, M | 1 |
| Crespel, A | 1 |
| Oka, E | 1 |
| Murakami, N | 1 |
| Ogino, T | 1 |
| Kobayashi, K | 1 |
| Ohmori, I | 1 |
| Akiyama, T | 1 |
| Ito, M | 1 |
| Fischer, W | 1 |
| Hahn, A | 1 |
| Fischenbeck, A | 1 |
| Stephani, U | 1 |
| Rainesalo, S | 1 |
| Peltola, J | 1 |
| Auvinen, A | 1 |
| Keränen, T | 1 |
| Konno, S | 1 |
| Steinhoff, BJ | 2 |
| Ueberall, MA | 1 |
| Siemes, H | 1 |
| Kurlemann, G | 1 |
| Schmitz, B | 1 |
| Bergmann, L | 1 |
| Zenkov, LR | 1 |
| Bednarek, N | 1 |
| Arbuès, AS | 1 |
| Motte, J | 1 |
| Sabouraud, P | 1 |
| Plouin, P | 1 |
| Morville, P | 1 |
| Gamble, CL | 1 |
| Kryscio, RJ | 1 |
| Aydin, OF | 1 |
| Senbil, N | 1 |
| Gürer, YK | 1 |
| Unay, B | 1 |
| Akin, R | 1 |
| Sarici, SU | 1 |
| Gok, F | 1 |
| Kurt, I | 1 |
| Gokcay, E | 1 |
| Ewen, JB | 1 |
| Comi, AM | 1 |
| Kossoff, EH | 1 |
| Chadwick, D | 2 |
| Marson, T | 1 |
| Cowling, BJ | 1 |
| Shaw, JE | 1 |
| Yuksel, A | 1 |
| Senocak, D | 1 |
| Sozuer, D | 1 |
| Keskin, G | 1 |
| Dirican, A | 1 |
| Cenani, A | 1 |
| Yalcin, E | 1 |
| Keating, A | 1 |
| Blahunka, P | 1 |
| Konishi, T | 2 |
| Naganuma, Y | 2 |
| Hongou, K | 1 |
| Murakami, M | 2 |
| Yamatani, M | 2 |
| Okada, T | 2 |
| Hongo, K | 1 |
| Yagi, S | 1 |
| Verity, CM | 1 |
| Hosking, G | 1 |
| Easter, DJ | 2 |
| Mayer, T | 1 |
| Specht, U | 1 |
| Callaghan, N | 1 |
| Majeed, T | 1 |
| O'Connell, A | 1 |
| Oliveira, DB | 1 |
| Murialdo, G | 1 |
| Galimberti, CA | 1 |
| Fonzi, S | 1 |
| Manni, R | 1 |
| Costelli, P | 1 |
| Parodi, C | 1 |
| Torre, F | 1 |
| Solinas, GP | 1 |
| Polleri, A | 1 |
| Tartara, A | 1 |
| De Deyn, PP | 1 |
| Mol, L | 1 |
| de Ridder-Vanderdeelen, P | 1 |
| Eerdekens, M | 1 |
| Richens, A | 1 |
| Davidson, DL | 1 |
| Cartlidge, NE | 1 |
| Lachkepiani, AN | 1 |
| Okudzhava, NV | 1 |
| Rukhadze, MD | 1 |
| Helmstaedter, C | 1 |
| Wagner, G | 1 |
| Elger, CE | 1 |
| Mutoh, K | 1 |
| Okuno, T | 1 |
| Mitsuyoshi, I | 1 |
| Hayakawa, T | 1 |
| Hamada, Y | 1 |
| Mikawa, H | 1 |
| Gao, L | 1 |
| Zhou, S | 1 |
| Wang, J | 1 |
| Laatikainen, TJ | 1 |
| Juntunen, KT | 1 |
| Myllylä, VV | 2 |
| Reynolds, EH | 1 |
| Heller, AJ | 1 |
| Walker, MC | 1 |
| Cockerell, OC | 1 |
| Sander, JW | 1 |
| Fisher, R | 1 |
| Tanganelli, P | 1 |
| Regesta, G | 1 |
| Mauri, JA | 1 |
| Iñiguez, C | 1 |
| Jericó, I | 1 |
| Díaz-Insa, S | 1 |
| Abad, F | 1 |
| Morales, F | 1 |
| Gigli, GL | 1 |
| Scalise, A | 1 |
| Silvestri, G | 1 |
| Diomedi, M | 1 |
| Placidi, F | 1 |
| Pomponi, MG | 1 |
| Masala, C | 1 |
| Christe, W | 1 |
| Krämer, G | 1 |
| Vigonius, U | 3 |
| Pohlmann, H | 3 |
| Brodie, MJ | 2 |
| Moore, A | 3 |
| Easter, D | 1 |
| O'Bryan-Tear, CG | 1 |
| Verity, C | 1 |
| Bill, PA | 1 |
| Guerreiro, CA | 1 |
| Kochen, S | 2 |
| Saffer, D | 1 |
| Guerreiro, MM | 1 |
| de Manreza, ML | 1 |
| Fejerman, N | 1 |
| Antoniuk, SA | 1 |
| Fischer, J | 1 |
| Labar, DR | 1 |
| Harden, C | 1 |
| Cantrell, D | 1 |
| Uthman, BM | 1 |
| Sackellares, JC | 1 |
| Ramsay, RE | 1 |
| Hayes, A | 1 |
| Greiner, M | 1 |
| Garofalo, E | 1 |
| Pierce, M | 1 |
| Eriksson, AS | 1 |
| Boreus, LO | 1 |
| Kennedy, BT | 1 |
| Haller, JS | 1 |
| Berkovic, SF | 1 |
| Shakespeare, A | 1 |
| Simeon, G | 1 |
| de Toffol, B | 1 |
| Hommet, C | 1 |
| Corcia, P | 1 |
| Autret, A | 1 |
| Edwards, SG | 1 |
| Hubbard, V | 1 |
| Aylett, S | 1 |
| Wren, D | 1 |
| Panayiotopoulos, CP | 1 |
| Verma, SP | 1 |
| Yunis, N | 1 |
| Lekos, A | 1 |
| Crausman, RS | 1 |
| Osorio, I | 1 |
| Reed, RC | 1 |
| Peltzer, JN | 1 |
| Rättyä, J | 1 |
| Turkka, J | 1 |
| Knip, M | 1 |
| Kotila, MA | 1 |
| Lukkarinen, O | 1 |
| Sykes, RM | 1 |
| Kmieć, T | 1 |
| Jóźwiak, S | 1 |
| Kuczyński, D | 1 |
| Karkowska, B | 1 |
| Bachański, M | 1 |
| Hennessy, MJ | 1 |
| Tighe, MG | 1 |
| Binnie, CD | 1 |
| Nashef, L | 1 |
| Giagante, B | 1 |
| Oddo, S | 1 |
| McKee, PJ | 1 |
| Percy-Robb, I | 1 |
| Bowery, NG | 1 |
| Bagetta, G | 1 |
| Nisticó, G | 1 |
| Britton, P | 1 |
| Whitton, P | 1 |
| Suzuki, T | 1 |
| Koizumi, J | 1 |
| Moroji, T | 1 |
| Shiraishi, H | 1 |
| Hori, T | 1 |
| Baba, A | 1 |
| Kawai, N | 1 |
| Tada, K | 1 |
| Fritze, J | 1 |
| Unsorg, B | 1 |
| Lanczik, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822] | 550 participants (Anticipated) | Observational | 2022-02-18 | Recruiting | |||
| A Therapeutic Confirmatory, Open-label, Multi-center, Randomized 2 Parallel Groups, Community-based Trial Studying the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral Tablets 250-500 mg b.i.d.) Compared to Sodium Valproate (1000 to 2000 mg/[NCT00175903] | Phase 3 | 1,701 participants (Actual) | Interventional | 2005-02-28 | Completed | ||
| Phase 3: Metabolism of Lamotrigine During Treatment With Oral Contraceptives[NCT00266149] | Phase 3 | 10 participants | Interventional | 2003-06-30 | Terminated | ||
| Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?[NCT06138847] | 119 participants (Anticipated) | Observational | 2023-01-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
32 reviews available for carbamazepine and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Second Generation of Antiepileptic Drugs and Oxidative Stress.
Topics: Anticonvulsants; Carbamazepine; Diazepam; Epilepsy; Epilepsy, Generalized; Fructose; Gabapentin; Hum | 2023 |
Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy?
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2023 |
The complexities underlying epilepsy in people with glioblastoma.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Glioblastoma; | 2023 |
Antiepileptic drugs: evolution of our knowledge and changes in drug trials.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Epilepsy, Generalized; Epileptic Syndrome | 2019 |
Current role of carbamazepine and oxcarbazepine in the management of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Oxcarbazepine; Topiramate | 2020 |
Update on first unprovoked seizure in children and adults: A narrative review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsies, Partial; Epilepsy, | 2021 |
Clinico-laboratory characteristics and outcome of patients with eucalyptus oil-induced/provoked seizures: A case series and systematic review of the published patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Eucalyptus | 2021 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, | 2018 |
Clobazam monotherapy for focal or generalized seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsies, Par | 2018 |
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, | 2018 |
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; Se | 2019 |
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epi | 2019 |
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures.
Topics: Animals; Anticonvulsants; Carbamazepine; Clinical Trials, Phase III as Topic; Epilepsy, Generalized; | 2014 |
Clobazam monotherapy for partial-onset or generalized-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsies, Par | 2014 |
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, | 2015 |
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; In | 2015 |
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, | 2016 |
Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; | 2016 |
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, | 2016 |
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; In | 2017 |
Epilepsy (generalised).
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis | 2010 |
Epilepsy (generalised).
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis | 2012 |
Carbamazepine versus phenobarbitone monotherapy for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; Humans; Ph | 2003 |
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Antipsychotic Agents; Carbamazepine; Child; Clinic | 2004 |
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Anticonvulsants; Carbamazepine; Child; Clinical Tr | 2004 |
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epile
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Cyclohexan | 2004 |
Lamotrigine versus carbamazepine monotherapy for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2006 |
New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Data Interpretation, Statistical; Epileps | 2007 |
Aggravation of generalized epilepsies.
Topics: Acute Disease; Anticonvulsants; Carbamazepine; Epilepsy, Generalized; gamma-Aminobutyric Acid; Human | 1998 |
[Anticonvulsants can aggravate idiopathic generalized epilepsy].
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Epilepsies, Myoclonic; Epilepsy, Ab | 1998 |
23 trials available for carbamazepine and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Oxcarbazepine oral suspension in pediatric patients with partial seizures and/or generalized tonic-clonic seizures: a multi-center, single arm, observational study in China.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Admi | 2017 |
Monotherapy of epilepsy in women: psychiatric and neuroendocrine aspects.
Topics: Adult; Anticonvulsants; Barbiturates; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Est | 2010 |
[Efficacy and safety of the mono- and combined therapy with oxcarbazepine in adult patients].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy, Genera | 2010 |
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2013 |
Oxcarbazepine in the treatment of childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Disease-Free Survival; Epilepsi | 2003 |
[Clinical efficacy and tolerability of topamax in combined therapy of epilepsy].
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Drug | 2003 |
The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Demography; Epilepsies, Partial; Epilepsy, Genera | 2005 |
Evaluation of renal tubular function in children taking anti-epileptic treatment.
Topics: Acetylglucosaminidase; Anticonvulsants; Biomarkers; Blood Urea Nitrogen; Carbamazepine; Child; Child | 2006 |
A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group.
Topics: Administration, Oral; Adolescent; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Generalized; | 1995 |
Propranolol in startle induced epileptic seizures.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clob | 1995 |
A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group.
Topics: Administration, Oral; Adult; Ambulatory Care Facilities; Carbamazepine; Clinical Protocols; Drug Eru | 1994 |
Valproate versus carbamazepine for seizures.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsies, Partial; Epilepsy, Complex Partial; Epile | 1993 |
Newer antiepileptic drugs as monotherapy: data on vigabatrin.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Over Studies | 1996 |
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Bl | 1997 |
Weight gain with valproate or carbamazepine--a reappraisal.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Over Studies; Dose-Respon | 1997 |
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Double-Blind Method; Epi | 1997 |
A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Double-Blind Method; Epilepsies | 1997 |
Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
Topics: Acetates; Adolescent; Adult; Ambulatory Care; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecar | 1997 |
Economic analysis of epilepsy treatment: a cost minimization analysis comparing carbamazepine and lamotrigine in the UK.
Topics: Anticonvulsants; Carbamazepine; Cost Control; Decision Support Techniques; Drug Costs; Epilepsies, P | 1998 |
Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; C | 1998 |
[Gabitril as an additive drug in therapy of intractable epileptic seizures in children].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Therapy, Combi | 2000 |
Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Partial; Epil | 2001 |
Spike-and-wave complexes and seizure exacerbation caused by carbamazepine.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsies, Partia | 2002 |
76 other studies available for carbamazepine and Convulsive Generalized Seizure Disorder
| Article | Year |
|---|---|
Factors involved in time reduction between seizure relapses in patients with epilepsy attending emergency rooms in Medellín, Colombia.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Colombia; Emergency Service, Hospital; Epilepsies, Parti | 2022 |
Prospective multisite cohort study of patient-reported outcomes in adults with new-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; Australia; Carbamazepine; Cohort Studies; Epilepsies, Partial; E | 2022 |
Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
Topics: Aged; Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Prescriptions; Epilepsy; Epilepsy, Gener | 2022 |
Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Oxcarbazepine | 2022 |
Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Ge | 2022 |
Seizures in Down Syndrome: An Update.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Down Syndrome; Epilepsies, Partial; Epileps | 2019 |
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina.
Topics: Adult; Anticonvulsants; Bosnia and Herzegovina; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilep | 2019 |
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsies, Partial; Epilepsy, Generalized | 2020 |
Development and validation of a predictive model for the diagnosis of neural antibody-mediated epilepsy/ seizure in patients with new-onset seizure or established epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; M | 2020 |
Antihistamines as a common cause of new-onset seizures: a single-center observational study.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; | 2021 |
Disulfiram-induced epileptic seizures.
Topics: Anticonvulsants; Carbamazepine; Disulfiram; Epilepsies, Partial; Epilepsy, Generalized; Epilepsy, To | 2021 |
[The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generali | 2021 |
Efficacy of phenobarbital in treating elderly epilepsy patients in rural northeast China: A community-based intervention trial.
Topics: Aged; Anticonvulsants; Carbamazepine; China; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; H | 2021 |
Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.
Topics: Adolescent; Adult; Anticonvulsants; Bangladesh; Carbamazepine; Child; Drug Combinations; Epilepsies, | 2013 |
Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy, Generalized; Female; Humans; Male; Middle Aged; Sei | 2014 |
Atherosclerotic effects of long-term old and new antiepileptic drugs monotherapy: a cross-sectional comparative study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; Cross- | 2015 |
Oxcarbazepine and its active metabolite, (S)-licarbazepine, exacerbate seizures in a mouse model of genetic generalized epilepsy.
Topics: Animals; Anticonvulsants; Brain; Brain Waves; Carbamazepine; Dibenzazepines; Disease Models, Animal; | 2015 |
[Stevens-Johnson syndrome/toxic epidermal necrolysis after initiation of carbamazepine in a HLA-B*15:02 gene carrier – screening in risk patients is recommended].
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; Epilepsy, Generalized; Female; HLA-B15 Antigen; | 2017 |
Characteristics of symptomatic epilepsy in patients with brain tumours.
Topics: Anticonvulsants; Brain Neoplasms; Carbamazepine; Diazepam; Epilepsy, Generalized; Female; Frontal Lo | 2009 |
The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Disease Models, Animal; Electri | 2010 |
A case of combined forms of unilateral heterotopia.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Brain Diseases; Carbamazepine; Cereb | 2012 |
Thyroid hormone levels in children receiving carbamazepine or valproate.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Dose-Response Rela | 2011 |
Fronto-polar epilepsy masquerading as juvenile myoclonic epilepsy.
Topics: Anticonvulsants; Brain; Carbamazepine; Diagnosis, Differential; Electroencephalography; Epilepsy, Fr | 2011 |
Myoclonus precipitated by oral suspension of oxcarbazepine in idiopathic generalized epilepsy.
Topics: Administration, Oral; Anticonvulsants; Carbamazepine; Drug Substitution; Electroencephalography; Epi | 2012 |
Lichen planus induced by carbamazepine: a case report.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Anticonvulsants; Betamethasone; Carbamazepi | 2012 |
Carbamazepine-induced non-epileptic myoclonus and tic-like movements.
Topics: Adult; Age of Onset; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Generalized; | 2012 |
[Idiopathic generalized epilepsy in young women: choise of treatment strategy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Generalized; Fe | 2012 |
The problem of non-superiority: what do we know after KOMET?
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Female; Humans; Levetira | 2013 |
Normally developed infant with a suppression burst pattern on electroencephalography in the neonatal period.
Topics: Anticonvulsants; Brain; Carbamazepine; Child Development; Child, Preschool; Electroencephalography; | 2002 |
[Tolerance of high dosage carbamazepine monotherapy in treatment of epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Electroe | 2002 |
Favorable outcome of epileptic blindness in children.
Topics: Acute Disease; Adolescent; Anticonvulsants; Blindness, Cortical; Carbamazepine; Child; Electroenceph | 2003 |
A pregnant woman with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Tolerance; Epilepsies, Partial; Epilepsy, Generalized; F | 2003 |
[Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epileps | 2003 |
Epilepsy versus antiepileptic drugs and gonadal function in men.
Topics: Androstenedione; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy, Generalized; Humans; | 2004 |
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epileps | 2004 |
Effect of epilepsy and antiepileptic drugs on male reproductive health.
Topics: Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone Sulfate; Epilepsies, | 2004 |
Telephone-induced seizures: a new type of reflex epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy, Complex Partial; Epilepsy, | 2004 |
Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Diagnostic Errors; Drug Adm | 2004 |
Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; | 2004 |
Influence of ethanol on the threshold for electroshock-induced seizures and electrically-evoked hippocampal afterdischarges.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Synergism; Electric Stimulatio | 2005 |
Induction of epileptic negative myoclonus by oxcarbazepine in symptomatic epilepsy.
Topics: Anticonvulsants; Atrophy; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; Dominance, Cerebr | 2004 |
Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics.
Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilep | 2005 |
[Half pitch lower sound perception caused by carbamazepine].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy, Generalized; Female; Hearing Disorders; Humans | 2005 |
[Anticonvulsive pharmacotherapy may aggravate epilepsy course].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epilepsy; | 2005 |
Familial rectal pain: a familial autonomic disorder as a cause of paroxysmal attacks in the newborn baby.
Topics: Amitriptyline; Anticonvulsants; Apnea; Autonomic Nervous System Diseases; Bradycardia; Bronchial Spa | 2005 |
Active control trials for epilepsy: avoiding bias in head-to-head trials.
Topics: Anticonvulsants; Bias; Carbamazepine; Control Groups; Dose-Response Relationship, Drug; Drug Adminis | 2006 |
Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing panencephalitis.
Topics: Anticonvulsants; Antiviral Agents; Carbamazepine; Child, Preschool; Diagnosis, Differential; Electro | 2006 |
Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsies, Myoclonic; Epilepsies, Pa | 2007 |
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Topics: Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Drug Costs; Drug Industry; Epilepsies, Partia | 2007 |
Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.
Topics: Anticonvulsants; Auditory Pathways; Brain Stem; Carbamazepine; Child; Child, Preschool; Epilepsies, | 1995 |
Carbamazepine-induced Stevens-Johnson syndrome in a child.
Topics: Anti-Bacterial Agents; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy, Generalized; Human | 1995 |
Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy.
Topics: Alpha Rhythm; Anticonvulsants; Carbamazepine; Child; Delta Rhythm; Electroencephalography; Epilepsie | 1995 |
Discontinuation of antiepileptic drug in childhood epilepsy: evaluation of the differences between epileptic syndromes.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Administration Schedule; E | 1994 |
A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients.
Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Chemical a | 1994 |
Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs.
Topics: Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dihydrotestosterone; Epilepsies, Partial; Ep | 1994 |
An open multicentre prospective study of the effects of monotherapy with controlled-release carbamazepine on newly diagnosed generalized tonic-clonic seizures.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparations; Epilep | 1994 |
[The optimization of the treatment of epilepsy with carbamazepine in puberty].
Topics: Adolescent; Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsies, Partial; Epilepsy, G | 1993 |
Differential effects of first antiepileptic drug application on cognition in lesional and non-lesional patients with epilepsy.
Topics: Attention; Brain Damage, Chronic; Carbamazepine; Cognition Disorders; Electroencephalography; Epilep | 1993 |
Induction of tonic spasms by carbamazepine: observations on 2 infants.
Topics: Carbamazepine; Child, Preschool; Dose-Response Relationship, Drug; Electroencephalography; Epilepsie | 1993 |
[The effects of phenytoin and carbamazepine on the cognitive function of epileptic patients].
Topics: Attention; Carbamazepine; Cognition; Epilepsy, Generalized; Humans; Memory; Phenytoin | 1993 |
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
Topics: Adolescent; Adult; Analysis of Variance; Carbamazepine; Cross-Sectional Studies; Epilepsies, Partial | 1993 |
Vigabatrin and carbamazepine monotherapy for newly diagnosed epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsies | 1996 |
[Epileptic seizures during sleep].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Carbamazepine; Electroencephalography; Epilepsy, Ge | 1996 |
Clinical case report: multiple idiosyncratic adverse effects of antiepileptic drugs in trisomy 9p.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Chromoso | 1996 |
No increase in carbamazepine-10,11-epoxide during addition of lamotrigine treatment in children.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Drug Monitoring; Epilep | 1997 |
Treatment of the epileptic patient in the dental office.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dental Care for Chronically Ill; Emergencies; Ep | 1998 |
Concordance of primary generalised epilepsy and carbamazepine hypersensitivity in monozygotic twins.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Diseases in Twins; Drug Eruptions; Electroencephalograph | 1999 |
Importance of specifying the type of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Contraindications; Diagnosis, Differential; Epilepsies, Parti | 1999 |
Carbamazepine-induced systemic lupus erythematosus presenting as cardiac tamponade.
Topics: Acute Disease; Anticonvulsants; Carbamazepine; Cardiac Tamponade; Diagnosis, Differential; Epilepsy, | 2000 |
Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Child; Dose-Res | 2000 |
Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.
Topics: Adolescent; Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone Sulfate; | 2001 |
Acute intermittent porphyria, seizures, and antiepileptic drugs: a report on a 3-year-old Nigerian boy.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Epilepsy, Generalized; Humans; Male; Phenobarbital | 2001 |
Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Electroencephalog | 1992 |
Intrahippocampal tetanus toxin produces generalized convulsions and neurodegeneration in rats: antagonism by NMDA receptor blockers.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Carbamazepine; Diazepam; Dizocilpine Maleate; | 1992 |
Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics.
Topics: Adult; Anticonvulsants; Carbamazepine; Copper; Drug Therapy, Combination; Epilepsy, Generalized; Fem | 1992 |
Interaction between carbamazepine and fluvoxamine.
Topics: Adult; Borderline Personality Disorder; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy, G | 1991 |